doi:10.1002/14651858.CD006815.pub2 Murrough JW, Yaqubi S, Sayed S, Charney DS
SeekPeptides members frequently discuss these psychological shifts in community forums, sharing strategies for navigating social situations, managing food relationships, and building sustainable habits that will outlast the medication itself
To treat obesity long-term, health care professionals and pharmacists can consider lifestyle modifications to address the decreased satiety and increased hunger that often occur after discontinuation of GLP-1 agonists
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may offer a safe and potentially beneficial option for managing obesity and metabolic comorbidities in adults with inflammatory bowel disease (IBD), according to a systematic review published in Alimentary Pharmacology & Therapeutics
Large peptide molecules cannot pass through the skin as smaller ones do